Moreover, high ShcA levels are enriched within the HER2 (ErbB2+) and basal (ER-/PR-/ErbB2-) subtypes and associate with poor outcome in breast cancer patients (Ursini-Siegel et al., 2010). This evidence concerns the gene ERBB2 and breast cancer.